Peter L. Anderson

21.7k citations

264 papers · 8.4k indexed · 1 hit paper · h-index 50

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.05%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in

Virology 126
- HIV Research and Treatment 126
Infectious Diseases 231
- HIV/AIDS Research and Interventions 193
- HIV/AIDS drug development and treatment 148

Co-authors: Jennifer J. Kiser Lane R. Bushman Courtney V. Fletcher Thomas N. Kakuda José Castillo‐Mancilla Robert M. Grant Albert Liu Edward M. Gardner
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (23 papers)Clinical Infectious Diseases (22 papers)AIDS (21 papers)Journal of Antimicrobial Chemotherapy (15 papers)AIDS Research and Human Retroviruses (14 papers)
Partner nations: United States South Africa Peru

In The Last Decade

Peter L. Anderson

253 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men 2012 · 760 citations

Peers

Countries citing papers authored by Peter L. Anderson

Since Specialization

Citations

This map shows the geographic impact of Peter L. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter L. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter L. Anderson more than expected).

Fields of papers citing papers by Peter L. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter L. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter L. Anderson. The network helps show where Peter L. Anderson may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter L. Anderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter L. Anderson Line = papers co-authored together Peter L. Anderson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharmacokinetic study in Thailand Journal of the International AIDS Society ·Akarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen J. Kerr, Rena Janamnuaysook, Siriporn Nonenoy, Piranun Hongchookiat, Rapee Trichavaroj, Yardpiroon Tawon, Jakkrapatara Boonruang, Nipat Teeratakulpisarn, Tim R. Cressey, Peter L. Anderson, Nittaya Phanuphak, (unknown)	2025	0
2	Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV Journal of Antimicrobial Chemotherapy ·Vincent Mainella, Brian R. Branchford, Travis Nemkov, Sarah R. Hosford, Ryan P Coyle, B. D. Johnson, Ye Ji Choi, Martin Williams, Jia‐Hua Zheng, Lane R. Bushman, Jennifer J. Kiser, Peter L. Anderson, Kristina M. Brooks	2025	0
3	Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression Clinical Infectious Diseases ·Helen L. Zhang, Meredith Mock, Lane R. Bushman, Peter L. Anderson, Jennifer J. Kiser, Susanna Naggie	2024	1
4	No observed bidirectional effect between tenofovir diphosphate concentrations and gender‐affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre‐exposure prophylaxis British Journal of Clinical Pharmacology ·Nimish Patel, Sheldon Morris, Leah Burke, Karen Chow, DeeDee Pacheco, Peter L. Anderson, Frank Z Stancyzk, Jill Blumenthal	2024	1
5	A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention The Journal of Infectious Diseases ·Sharon A. Riddler, Clifton W. Kelly, Craig Hoesley, Ken Ho, Jeanna Piper, Stacey Edick, Faye Heard, Gustavo F. Doncel, Sherri Johnson, Peter L. Anderson, Rhonda M. Brand, Ratiya Pamela Kunjara Na Ayudhya, José A. Bauermeister, Sharon L. Hillier, Craig W. Hendrix	2024	1
6	Antiretroviral therapy adherence among peripartum women with HIV in Kenya: an explanatory mixed methods study using dry blood spot measures and narrative interviews AIDS Care ·Karen Hampanda, H. Grubbs, José Castillo‐Mancilla, Peter L. Anderson, Jennifer E. Thorne, Anna Helová, Janet M. Turan, Maricianah Onono, Lisa Abuogi	2024	0
7	Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection Antimicrobial Agents and Chemotherapy ·Ji‐Hyun Bae, Marwa Tantawy, Yan Gong, Taimour Langaee, Margaret Lartey, Vincent Ganu, Kenneth Tachi, Oluwayemisi Ojewale, Adjoa Obo-Akwa, Isaac Boamah, Lane R. Bushman, Lucas Ellison, Hongmei Yang, Peter L. Anderson, Awewura Kwara	2024	1
8	Development and validation of an LC-MS/MS method to quantify the alcohol biomarker phosphatidylethanol 16:0/18:1 in dried blood spots for clinical research purposes Journal of Chromatography B ·Lana M. Salah, Lane R. Bushman, Kristina M. Brooks, Peter L. Anderson, Jennifer J. Kiser	2023	0
9	High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study PLoS Medicine ·Lynn T. Matthews, Esther C. Atukunda, Moran Owembabazi, Kato Paul Kalyebera, Christina Psaros, Pooja Chitneni, Craig W. Hendrix, Mark A. Marzinke, Peter L. Anderson, Oluwaseyi O. Isehunwa, Kathleen E. Hurwitz, Kara Bennett, Winnie Muyindike, David R. Bangsberg, Jessica E. Haberer, Jeanne Marrazzo, Mwebesa Bwana	2023	16
10	Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates Science Translational Medicine ·Fernanda P. Pons‐Faudoa, Nicola Di Trani, Simone Capuani, Jocelyn Nikita Campa‐Carranza, Bharti Nehete, Sanjeev Sharma, Kathryn A. Shelton, Lane R. Bushman, Farah Abdelmawla, Martin Williams, Laura Roon, David Nerguizian, Corrine Ying Xuan Chua, Michael Ittmann, Joan E. Nichols, Jason T. Kimata, Peter L. Anderson, Pramod N. Nehete, Roberto C. Arduino, Alessandro Grattoni	2023	15
11	Updating the Adherence–Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women Clinical Infectious Diseases ·Peter L. Anderson, Mark A. Marzinke, David V. Glidden	2023	17
12	Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men Sexually Transmitted Infections ·Mark A. M. van den Elshout, Elske Hoornenborg, Liza Coyer, Peter L. Anderson, Udi Davidovich, Henry J.C. de Vries, Maria Prins, Maarten F. Schim van der Loeff	2022	4
13	Cumulative tenofovir diphosphate exposure in persons with HIV taking single‐ vs. multiple‐tablet regimens Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Ryan P Coyle, Mary Morrow, Samantha MaWhinney, Stacey S. Coleman, Jia‐Hua Zheng, Lucas Ellison, Lane R. Bushman, Jennifer J. Kiser, Peter L. Anderson, José Castillo‐Mancilla	2022	0
14	Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial Journal of the International AIDS Society ·Jennifer Velloza, Sybil Hosek, Deborah Donnell, Peter L. Anderson, Mike Chirenje, Nyaradzo Mgodi, Linda‐Gail Bekker, Sinéad Delany‐Moretlwe, Connie Celum, (unknown)	2021	25
15	Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant Pharmaceutics ·Fernanda P. Pons‐Faudoa, Nicola Di Trani, Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman, Jiaqiong Xu, Dorothy E. Lewis, Sandra Demaria, Trevor Hawkins, James F. Rooney, Mark A. Marzinke, Jason T. Kimata, Peter L. Anderson, Pramod N. Nehete, Roberto C. Arduino, K. Jagannadha Sastry, Alessandro Grattoni	2020	99
16	Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles AIDS Care ·David Goodman‐Meza, Matthew R. Beymer, Ryan Kofron, K. Rivet Amico, Christina Psaros, Lane R. Bushman, Peter L. Anderson, Robert Bolan, Wilbert Jordan, James F. Rooney, Amy Rock Wohl, Raphael J. Landovitz	2019	19
17	Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With Men JAIDS Journal of Acquired Immune Deficiency Syndromes ·Martin Hoenigl, Adiba Hassan, David J. Moore, Peter L. Anderson, Katya Corado, Michael P. Dubé, Eric Ellorin, Jill Blumenthal, Sheldon Morris, (unknown)	2019	17
18	Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing Antimicrobial Agents and Chemotherapy ·José Castillo‐Mancilla, Sharon M. Seifert, Kayla Campbell, Stacey S. Coleman, Kevin McAllister, Jia‐Hua Zheng, Edward M. Gardner, Albert Liu, David V. Glidden, Robert M. Grant, Sybil Hosek, Craig M. Wilson, Lane R. Bushman, Samantha MaWhinney, Peter L. Anderson	2016	56
19	Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection Antimicrobial Agents and Chemotherapy ·Liviawati S. Wu, Joseph E. Rower, James R. Burton, Peter L. Anderson, Kyle P. Hammond, Fafa Baouchi‐Mokrane, Gregory T. Everson, Thomas Urban, David Z. D’Argenio, Jennifer J. Kiser	2015	25
20	Static FEA of cortical bone tensile test with variations in modulus identified from micro-CT scans ePrints Soton (University of Southampton) ·John R. Cotton, Peter Zioupos, Keith Winwood, Peter L. Anderson, G.R. Davies, Marianne Taylor	2001	1

About Peter L. Anderson

Peter L. Anderson is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Hepatology, having authored 264 papers that have together received 8.4k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (193 papers), HIV/AIDS drug development and treatment (148 papers), HIV Research and Treatment (126 papers), HIV, Drug Use, Sexual Risk (56 papers), HIV-related health complications and treatments (29 papers), Adolescent Sexual and Reproductive Health (18 papers), LGBTQ Health, Identity, and Policy (15 papers) and Sex work and related issues (13 papers). The work is most often cited by research in Virology (3.0k citations), Infectious Diseases (7.0k citations), Epidemiology (3.5k citations), Emergency Medicine (923 citations) and General Health Professions (1.1k citations). Peter L. Anderson has collaborated with scholars based in United States, South Africa and Peru. Frequent co-authors include Jennifer J. Kiser, Lane R. Bushman, Courtney V. Fletcher, Thomas N. Kakuda, José Castillo‐Mancilla, Robert M. Grant, Albert Liu, Edward M. Gardner, Susan Buchbinder and Joseph E. Rower. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, AIDS, Journal of Antimicrobial Chemotherapy and AIDS Research and Human Retroviruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact